Headquartered in Crystal Lake, IL, Aptar provides a range of dispensing, sealing, and active packaging solutions and this week purchased the two companies for a combined enterprise value of approximately $50m.
Nanopharm provides analytical and drug development services with a focus on orally inhaled and nasal drug products and is located in Newport, UK, while Gibsonia, PA-based Gateway Analytical provides particulate detection and predictive analytical services to customers developing injectable medicines.
According to Aptar, the acquisitions are in line with the company’s strategy to expand its services portfolio.
The addition will enable the company to collaborate with customers earlier, supporting drug formulation and delivery.
Aptar has previously voiced plans to expand globally as part of a multi-year investment plan in response to expected growth in the injectable market driven by biologics and vaccines.